Vivaglobin



Indications and Reactions:

Role Indications Reactions
Primary
Immunodeficiency Common Variable 46.5%
Hypogammaglobulinaemia 17.0%
Immunodeficiency 9.6%
Primary Immunodeficiency Syndrome 4.6%
Blood Immunoglobulin G Decreased 3.5%
Selective Igg Subclass Deficiency 3.5%
Combined Immunodeficiency 2.5%
Immune System Disorder 1.4%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy 1.1%
Chronic Lymphocytic Leukaemia 1.1%
Epstein-barr Virus Infection 1.1%
Humoral Immune Defect 1.1%
Immunosuppression 1.1%
Infection 1.1%
Polyneuropathy 1.1%
Selective Polysaccharide Antibody Deficiency 1.1%
Axonal Neuropathy 0.7%
Hypoproteinaemia 0.7%
Immunisation 0.7%
Immunoglobulins Decreased 0.7%
Vomiting 11.1%
Urticaria 10.4%
Meningitis Aseptic 8.9%
Transmission Of An Infectious Agent Via A Medicinal Product 6.7%
Dyspnoea 5.2%
Headache 5.2%
Weight Decreased 5.2%
Pain In Extremity 4.4%
Wrong Technique In Drug Usage Process 4.4%
Death 3.7%
Deep Vein Thrombosis 3.7%
Nausea 3.7%
Oedema Peripheral 3.7%
Pyrexia 3.7%
Vasculitis 3.7%
Visual Impairment 3.7%
Wheezing 3.7%
Blood Glucose Increased 3.0%
Convulsion 3.0%
Hepatitis B Surface Antigen Positive 3.0%
Secondary
Immunodeficiency Common Variable 46.5%
Hypogammaglobulinaemia 9.7%
Product Used For Unknown Indication 8.0%
Immunodeficiency 6.9%
Humoral Immune Defect 6.5%
Primary Immunodeficiency Syndrome 5.2%
Blood Immunoglobulin G Decreased 3.4%
Premedication 2.4%
Immune System Disorder 1.9%
Selective Igg Subclass Deficiency 1.9%
Asthma 1.3%
Respiratory Tract Infection 1.1%
Combined Immunodeficiency 0.9%
Headache 0.9%
Multiple Sclerosis 0.9%
Developmental Delay 0.6%
Hypoproteinaemia 0.6%
Immunosuppression 0.6%
Acute Graft Versus Host Disease 0.4%
Antibody Test Negative 0.4%
Herpes Simplex Serology Positive 16.3%
Transmission Of An Infectious Agent Via A Medicinal Product 11.9%
Hepatitis B Surface Antigen Positive 7.9%
Weight Decreased 5.7%
Vasculitis 5.3%
Pain In Extremity 4.8%
Wheezing 4.8%
Blood Glucose Increased 4.4%
Hepatic Steatosis 4.4%
Meningitis Aseptic 4.4%
Treatment Noncompliance 3.5%
Convulsion 3.1%
Neurological Symptom 3.1%
Pruritus Generalised 3.1%
Thrombosis 3.1%
Vomiting 3.1%
Wrong Technique In Drug Usage Process 3.1%
Death 2.6%
Dyspnoea 2.6%
Nausea 2.6%
Concomitant
Drug Use For Unknown Indication 48.1%
Immunodeficiency Common Variable 13.2%
Hypertension 4.7%
Gastrooesophageal Reflux Disease 3.9%
Product Used For Unknown Indication 3.9%
Chronic Obstructive Pulmonary Disease 3.1%
Multiple Allergies 3.1%
Premedication 2.3%
Anxiety 1.6%
Asthma 1.6%
Chronic Lymphocytic Leukaemia 1.6%
Convulsion 1.6%
Crohn's Disease 1.6%
Hypothyroidism 1.6%
Immunodeficiency 1.6%
Menopause 1.6%
Migraine 1.6%
Restless Legs Syndrome 1.6%
Selective Igg Subclass Deficiency 1.6%
Blood Cholesterol Abnormal 0.8%
Vomiting 24.0%
Death 8.0%
Dyspnoea 8.0%
Oxygen Saturation Decreased 8.0%
Cough 4.0%
Crohn's Disease 4.0%
Drug Ineffective 4.0%
Herpes Simplex Serology Positive 4.0%
Hypersensitivity 4.0%
Lip Swelling 4.0%
Malaise 4.0%
Renal Pain 4.0%
Speech Disorder 4.0%
Thrombocytopenia 4.0%
Urticaria 4.0%
Vulvovaginitis Streptococcal 4.0%
Weight Increased 4.0%